The beginning of the end: Death signaling in early involution

Journal of Mammary Gland Biology and Neoplasia

Volumn 12, Issue 1, 2007, Pages 3-13

  Baxter, Fiona O ^a   Neoh, Kevin ^a   Tevendale, Maxine C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Early involution; NF B; PI(3)K; Stat3; TGF

Indexed keywords

CYTOKINE; DEATH RECEPTOR; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED WEAK INDUCER INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST DEVELOPMENT; CELL SURVIVAL; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; INVOLUTION; LACTATION; LACTATION INHIBITION; LIGAND BINDING; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PREGNANCY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SUCKLING; TISSUE REGENERATION; TRANSCRIPTION REGULATION; TUMOR CELL; WEANING;

ANIMALS; APOPTOSIS; FEMALE; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; SIGNAL TRANSDUCTION; WEANING;

EID: 33947155299     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-007-9033-9     Document Type: Review

References (106)

1. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, Jaggi R. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 1994;9(4):1213-23.
2. Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, et al. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 1996;122:181-93.
3. Furth PA, Bar-Peled U, Li M. Apoptosis and mammary gland involution: reviewing the process. Apoptosis 1997;2(1):19-24.
4. Melino G, Knight RA, Nicotera P. How many ways to die? How many different models of cell death? Cell Death Differ 2005;12(2):1457-62.
5. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
6. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 2004;6(2):92-109.
7. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004;6:R75-91.
8. Baxter FO, Came PJ, Abell K, Kedjouar B, Huth M, Rajewsky K, et al. IKKb/ 2 induces TWEAK and apoptosis in mammary epithelial cells. Development 2006;133(17):3485-94.
9. Rosenblatt J, Raff MC, Cramer LP. An epithelial cell destined for apoptosis signals its neighbors to extrude it by and actin- and myosin-dependent mechanism. Curr Biol. 2001;11(23):1847-57.
10. Feng ZW, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell-death in the mouse mammary-gland. J Cell Biol. 1995;131:1095-103.
11. Li M, Liu X, Robinson G, Bar-Peled U, Wagner KU, Young WS, Hennighausen L, et al. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci USA. 1997;94(7):3425-30 (Apr 1).
12. Nguyen AV, Pollard JW. Transforming growth factor beta 3 induces cell death during the first stage of mammary gland involution. Development 2000;127:3107-18.
13. Kritikou EA, Sharkey A, Abell K, Came PJ, Anderson E, Clarkson RWE, et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 2003;130(15):3459-68.
14. Schere-Levy C, Buggiano V, Quaglino A, Gattelli A, Cirio MC, Piazzon I, et al. Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res 2003;282(1):35-47 (Jan 1).
15. Clarkson RW, Heeley JL, Chapman R, Aillet F, Hay RT, Wyllie AH, et al. NF-κB inhibits apoptosis in murine mammary epithelia. J Biol Chem 2000;275(17):12737-42.
16. Schmitt-Ney M, Happ B, Hofer P, Hynes NE, Groner B. Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis. Mol Endocrinol 1992;6(12):1988-97.
17. Liu X, Robinson GW, Hennighausen L. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol 1996;10(12):1496-506.
18. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004;6:R75-91.
19. Monks J, Rosner D, Geske FJ, Lehman L, Neville MC, Fadok VA. Epithelial cells as phagocytes: Apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005;12:107-14.
20. Hanayama R, Nagata S. Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci USA 2005;102(46):16886-91.
21. Atabai K, Fernandez, R, Huang, X, Ueki, I, Kline, A, Li, Y, et al. Mfge8 is critical for mammary gland remodeling during involution. Mol Biol Cell 2005;16(12):5528-37.
22. Sheppard et al. (2006), this issue.
23. Schwertfeger KL, Richert, MM, Anderson, SM. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol 2001;15(6):867-81.
24. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999;13:2604-16.
25. Sutherland et al. (2006), this issue.
26. Clarkson RW, Boland MP, Kritikou EA, Lee JM, Freeman TC, Tiffen PG, et al. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol Endocrinol 2006;20(3):675-85.
27. Kritikou EA, Sharkey A,. Abell K, Came PJ, Anderson E, Clarkson RWE, et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 2003;130(15):3459-68.
28. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, et al. C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 2005;132:4675-85.
29. Tiffen P. PhD Thesis, University of Cambridge; 2006.
30. Heinrich PC, Behrmann I, Muller-Newen G, Shaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998;334(2):297-314
31. Kritikou EA, Sharkey A, Abell K, Came PJ, Anderson E, Clarkson RWE, et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 2003;130(15):3459-68.
32. Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, et al. Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells 2005;10:1051-63.
33. Wymann MP, Zvelebil M, Laffargue M. Phosphoinositide 3-kinase signalling - which way to target? TIPS 2003;24(7):366-76.
34. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001;70:535-602.
35. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998;95(1):29-39.
36. Hunter S, Koch BL, Anderson SM. Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. Mol Endocrinol 1997;11(9):1213-22.
37. Hunter S, Burton EA, Wu SC, Anderson SM. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem 1999;274(4):2097-106.
38. Strange R, Metcalfe T, Thackray L, Dang M. Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech 2001;52(2):171-81.
39. Widmann C, Gibson S, Johnson GL. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 1998;273(12):7141-7.
40. Gilmore AP, Metcalfe AD, Romer LH, Streuli CH. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol 2000;149(2):431-46.
41. Strange R, Metcalfe T, Thackray L, Dang M. Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech 2001;52(2):171-81.
42. Farrelly N, Lee YJ, Oliver J, Dive C, Streuli CH. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 1999;144:1337-47.
43. Neuenschwander S, Schwartz A, Wood TL, Roberts CT, Henninghausen L, Leroith D. Involution of the lactating mammary-gland is inhibited by the Igf system in a transgenic mouse model. J Clin Invest 1996;97:2225-32.
44. Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR, Rosen JM. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 1996;137:321-30.
45. Moorehead RA, Fata JE, Johnson MB, Khokha R. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Differ 2001;8:16-29.
46. Tonner E, Barber MC, Travers MT, Logan A, Flint DJ. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 1997;138:5101-7.
47. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999;13:2604-16.
48. Schwertfeger KL, McManaman JL, Palmer CA, Neville MC, Anderson SM. Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res 2003;44(6):1100-12.
49. Schwertfeger KL, Richert MM, Anderson SM. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol 2001;15(6):867-81.
50. Abell K, Bilancio A, Clarkson RW, Tiffen PG, Altaparmakov AI, Burdon TG, et al. Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol 2005;7(4):392-8.
51. Strange R, Metcalfe T, Thackray L, Dang M. Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech 2001;52(2):171-81.
52. Schwertfeger KL, Richert MM, Anderson SM. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol 2001;15(6):867-81.
53. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 2001;21(6):2203-12.
54. Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI. Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene 2002;21(2):198-206.
55. Abell K, Bilancio A, Clarkson RW, Tiffen PG, Altaparmakov AI, Burdon TG, et al. Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol 2005;7(4):392-8.
56. Lacher MD, Siegenthaler A, Jager R, Yan X, Hett S, Xuan L, et al. Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Differ 2003;10(5):528-38.
57. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282(5392):1318-21.
58. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96(6):857-68.
59. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000;10(19):1201-4.
60. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
61. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
62. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, et al. Target genes of beta-catenin-T cell-factor lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999;96:1603-1608.
63. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 1999;9(11):601-4.
64. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001;15:2203-8.
65. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001a;276(42):38349-52.
66. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001b;292(5522):1728-31.
67. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 2003 Jul;112(2):197-208. Epub 2003 Jul 3.
68. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, et al. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 2005;25(5):1869-78 (Mar).
69. Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, et al. Essential role of protein kinase B gamma (PKB gamma/ Akt3) in postnatal brain development but not in glucose homeostasis. Development 2005;132(13):2943-54 (Jul).
70. Boxer RB, Stairs DB, Dugan KD, Notarfrancesco KL, Portocarrero CP, Keister BA, et al. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab. 2006;4(6):475-90.
71. Roberts AB, Sporn MB. The transforming growth factor-betas. In: Roberts AB, editor. Peptide Growth Factors and Their Receptors. Berlin Heidelberg New York: Springer; 1990. p. 419-72.
72. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett 2006;580(12):2811-20.
73. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massague J. The TGF beta receptor activation process: An inhibitor- to substrate-binding switch. Mol Cell 2001;8(3):671-82.
74. Zhang Y, Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol 1999;9:274-9.
75. Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000;12:235-43.
76. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett. 2006;580(12):2811-20.
77. Roberts AB, Sporn MB. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 1992;32(2):91-8 (June).
78. Daniel CW, Robinson S, Silberstein GB. The transforming growth factors beta in development and functional differentiation of the mouse mammary gland. Adv Exp Med Biol 2001;501:61-70.
79. Serra R, Crowley MR. TGF-beta in mammary gland development and breast cancer. Breast Dis 2003;18:61-73.
80. Nguyen AV, Pollard JW. Transforming growth factor beta 3 induces cell death during the first stage of mammary gland involution. Development 2000;127:3107-18.
81. Prince JM, Klinowska TC, Marshman E, Lowe ET, Mayer U, Miner J, et al. Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev Dyn 2002;223(4):497-516.
82. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R. Extracellular-matrix regulates expression of the TGF-beta-1 gene. J Cell Biol 1993;120:253-60.
83. Siegel PM, Massagué, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003;3:807-20.
84. Yang YA, Tang B, Robinson G, Hennighausen L, Brodie SG, Deng CX, et al. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ 2002;13(3):123-30.
85. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol 2001;3:708-14.
86. Yu L, Hebert MC, Zhang YE. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 2002;21:3749-59.
87. Gottfried Y, Rotem A, Lotan R, Steller H, Larisch S. The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. EMBO J 2004;23:1627-35.
88. Schuster N, Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 2002;307(1):1-14.
89. Remy I, Montmarquette A, Michnick SW. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 2004;6:358-65.
90. Conery AR, Cao Y, Thompson EA, Townsen CM, Ko TC Jr, Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol 2004;6:366-72.
91. Nguyen AV, Pollard JW. Transforming growth factor beta 3 induces cell death during the first stage of mammary gland involution. Development 2000;127:3107-18.
92. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 2000;18:621-63.
93. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappaB signaling pathway. Science 2001;293(5534):1495-9.
94. Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, et al. IKKα provides an essential link between RANK signalling and cyclin D1 expression during mammary gland development. Cell 2001;107:763-75.
95. Brantley DM, Yull FE, Muraoka RS, Hicks DJ, Cook CM, Kerr LD. Dynamic expression and activity of NF-κB during post-natal mammary gland morphogenesis. Mech Dev 2000;97(1-2):149-55.
96. Geymayer S, Doppler W. Activation of the NF-κB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. FASEB J 2000;14:1159-70.
97. Henninghausen L, Robinson GW. Signaling pathways in mammary gland development. Dev Cell 2001;1:467-75.
98. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 2000;18:621-63.
99. Baetu TM, Kwon H, Sharma S, Grandvaux N, Hiscott J. Disruption of NF-kappaB signalling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J Immunol 2001;167(6):3164-73.
100. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappaB and AP-1. Mol Cell 1998;1(4):543-51.
101. Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: Role of NF-kappaB. J Immunol 1995;155:902-8.
102. Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, et al. Roles of Fas and Fas ligand during mammary gland remodelling. J Clin Invest 2000;106(10):1209-20.
103. Almasan A, Ashkenazi A. Apo2L/TRAIL: Apoptosis signalling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003;14:337-48.
104. Green KA, Streuli CH. Apoptosis regulation in the mammary gland. Cell Mol Life Sci;2004;61(15):1867-83 (Aug).
105. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 2000;18:621-63.
106. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004;6:R75-91.